Relative Efficacy of Sacubitril-Valsartan, Vericiguat, and SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Network Meta-Analysis
Alberto Aimo, Konstantinos Pateras, Κimon Stamatelopoulos, Antoni Bayés‐Genís, Carlo Lombardi, Claudio Passino, Michele Emdin, Georgios Georgiopoulos
Topics & Concepts
ValsartanMedicineSacubitrilSacubitril, ValsartanEjection fractionInternal medicineHeart failureEmpagliflozinDapagliflozinHazard ratioCardiologyDiabetes mellitusType 2 diabetesConfidence intervalEndocrinologyBlood pressureDiabetes Treatment and ManagementHeart Failure Treatment and ManagementHyperglycemia and glycemic control in critically ill and hospitalized patients